癌症：为何肿瘤会消耗色氨酸。 - Suppr | 超能文献

相似文献

1

Cancer: Why tumours eat tryptophan.癌症：为何肿瘤会消耗色氨酸。

Nature. 2011 Oct 12;478(7368):192-4. doi: 10.1038/478192a.

2

Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.原发性脑肿瘤中色氨酸代谢的芳基烃受体和内在肿瘤成分的犬尿氨酸途径研究。

J Neurooncol. 2018 Sep;139(2):239-249. doi: 10.1007/s11060-018-2869-6. Epub 2018 Apr 17.

3

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.一种人类芳香烃受体的内源性肿瘤促进配体。

Nature. 2011 Oct 5;478(7368):197-203. doi: 10.1038/nature10491.

4

The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors.芳香烃受体（AhR）在脑肿瘤中的作用。

Int J Mol Sci. 2020 Apr 20;21(8):2863. doi: 10.3390/ijms21082863.

5

Neuroprotection in ischemic stroke: AhR we making progress?缺血性卒中的神经保护：芳烃受体（AhR）方面我们有进展吗？

Circulation. 2014 Dec 2;130(23):2002-4. doi: 10.1161/CIRCULATIONAHA.114.013533. Epub 2014 Oct 30.

6

EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway.EWS-FLI1通过阻断色氨酸经由犬尿氨酸途径的分解，损害芳烃受体激活。

FEBS Lett. 2016 Jul;590(14):2063-75. doi: 10.1002/1873-3468.12243. Epub 2016 Jun 21.

7

Kynurenine signaling through the aryl hydrocarbon receptor: Implications for aging and healthspan.犬尿氨酸信号通过芳香烃受体：对衰老和健康寿命的影响。

Exp Gerontol. 2020 Feb;130:110797. doi: 10.1016/j.exger.2019.110797. Epub 2019 Nov 28.

8

The kynurenine pathway in brain tumor pathogenesis.脑肿瘤发病机制中的犬尿氨酸途径。

Cancer Res. 2012 Nov 15;72(22):5649-57. doi: 10.1158/0008-5472.CAN-12-0549. Epub 2012 Nov 9.

9

The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma.芳香烃受体是胶质母细胞瘤中一种肿瘤抑制样基因。

J Biol Chem. 2019 Jul 19;294(29):11342-11353. doi: 10.1074/jbc.RA119.008882. Epub 2019 Jun 6.

10

Evading immunity: new enzyme implicated in cancer.逃避免疫：与癌症相关的新酶

J Natl Cancer Inst. 2012 Mar 7;104(5):349-52. doi: 10.1093/jnci/djs152. Epub 2012 Feb 20.

引用本文的文献

1

Metabolomics as a tool for understanding and treating triple-negative breast cancer.代谢组学作为理解和治疗三阴性乳腺癌的一种工具。

Naunyn Schmiedebergs Arch Pharmacol. 2025 May 2. doi: 10.1007/s00210-025-04234-4.

2

Electrochemical Analysis and Inhibition Assay of Immune-Modulating Enzyme, Indoleamine 2,3-Dioxygenase.免疫调节酶吲哚胺 2,3-双加氧酶的电化学分析及抑制测定

Pharmaceuticals (Basel). 2025 Feb 28;18(3):352. doi: 10.3390/ph18030352.

3

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review.

本文引用的文献

1

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.一种人类芳香烃受体的内源性肿瘤促进配体。

Nature. 2011 Oct 5;478(7368):197-203. doi: 10.1038/nature10491.

2

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.伊马替尼通过抑制 IDO 增强胃肠道间质瘤中的抗肿瘤 T 细胞反应。

Nat Med. 2011 Aug 28;17(9):1094-100. doi: 10.1038/nm.2438.

3

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.癌症免疫编辑：整合免疫在癌症抑制和促进中的作用。